Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Sep;32(8):666-70.
doi: 10.1007/BF03345738. Epub 2009 May 12.

17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence

Affiliations

17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence

S Bertelloni et al. J Endocrinol Invest. 2009 Sep.

Abstract

Objective: Aim of this study is to report on basal clinical phenotype and follow up after diagnosis, of patients with 17beta-hydroxysteroid-dehydrogenase type 3 (17beta-HSD3) deficiency in Italy.

Setting: Pediatric Endocrine Departments, University Hospitals.

Patients: The cases of 5 Italian subjects affected by 17beta-HSD3 deficiency are presented in this study.

Interventions: Laboratory and genetic assessment. Gonadectomy and female sex assignment (4 patients) or GnRH analog therapy to regress puberty and gender identity disorder (1 patient).

Results: Presentation lasted from pregnancy (pre-natal diagnosis of a 46,XY fetus with female external genitalia) to infancy (inguinal hernia containing testes/clitoromegaly) and adolescence (virilisation). All subjects but one (subject 1, Central-Northern Italy) were from small areas of Southern Italy. Endocrine data (baseline and/or stimulated testosterone/ Delta4-androstenedione ratio) were informative. Two girls were homozygous for 17beta-HSD3 gene mutations (G289S/G289S; R80W/R80W), while the others were compound heterozygous (IVS325+4 A>T/A203V; L212Q/M235V; R80W/A235E). Four patients were confirmed as females and were well-adjusted with assigned sex; gender identity disorder improved during treatment with GnRH analog in the last subject.

Conclusions: 17betaHSD3 deficiency may present from pregnancy to puberty for different clinical issues. Albeit testosterone/Delta4-androstenedione ratio represents the most accurate endocrine marker to diagnose the disorder, hCGstimulation is mandatory in pre-puberty. Molecular analysis of 17beta-HSD3 gene should be performed to confirm the diagnosis. Temporary GnRH analog treatment may regress gender identity disorder and provide time to confirm or change the birth sex assignment. Female individuals seems to be compliant with their sex, providing that virilisation does not occur. In Italy, the disorder seems to be more prevalent in the Southern regions and shows genetic heterogeneity.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Endocrinol Invest. 2006 Jul-Aug;29(7):581-93 - PubMed
    1. J Clin Endocrinol Metab. 1998 Aug;83(8):2855-60 - PubMed
    1. Pediatr Endocrinol Rev. 2006 Sep;4(1):28-31 - PubMed
    1. J Pediatr. 1981 Nov;99(5):742-3 - PubMed
    1. Genet Med. 2007 Jun;9(6):348-57 - PubMed

Substances

LinkOut - more resources